| RF | radial fiber; radio frequency; receptive field; regurgitant fraction; Reitland-Franklin [unit]; rela... |
|---|---|
| PIF | paratoid isoelectric focusing variant protein; peak inspiratory flow; proinsulin-free; prolactin-inh... |
| MAP | malignant atrophic papulosis; mandibular angle plane; maturation-activated protein; maximal aerobic ... |
| MBP | major basic protein; maltose-binding protein; management by policy; mannose-binding protein; mean bl... |
| RP | radial pulse; radiopharmaceutical; rapid processing [of film]; Raynaud phenomenon; reactive protein;... |
| VPF/VEGF | Vascular permeability factor/vascular endothelial growth factor |
|---|---|
| Factor XII | factor |
| CRF-BP | Corticotropin releasing factor binding protein |
| Grb2 | Growth Factor Receptor-Bound protein 2 |
| GRB2 | Growth factor receptor binding protein-2 |
| helminthiasis, animal | Infestation of animals with parasitic worms of the helminth class. The infestation may be experimental or veterinary. (12 Dec 1998) |
|---|---|
| hepatitis, viral, animal | Viral hepatitis in animals. (12 Dec 1998) |
| protozoan infections, animal | Infections with unicellular organisms of the subkingdom protozoa. The infections may be experimental or veterinary. (12 Dec 1998) |
| sentinel animal | An animal deliberately placed in a particular environment to detect the presence of an infectious agent, such as a virus. (05 Mar 2000) |
| Houssay animal | An animal that has been pancreatectomised and hypophysectomised. Named after the discoverer of the principle that animal's are more sensitive to insulin after removal of the pituitary, and that after this operation the intensity of diabetes in depancreatised animal's is diminished. (05 Mar 2000) |
| sex behaviour, animal | Sexual activities of animals. (12 Dec 1998) |
| normal animal | In research, an experimental animal that has neither suffered an attack of a particular disease nor received an injection of a specific microorganism or its toxin. (05 Mar 2000) |
| disease models, animal | Animal disease whose pathologic mechanisms are sufficiently similar to those of a different human disease for the animal disease to serve as a model. The animal disease may be either induced or naturally occurring so long as it is not the same clinical entity as the disease for which it serves as a model. E.g., scrapie is an animal model for multiple sclerosis, which has never been found or induced in an animal. (12 Dec 1998) |
| eliminative behaviour, animal | Behaviour associated with the elimination of feces and urine from the body. (12 Dec 1998) |
| toxoplasmosis, animal | Acquired infection of non-human animals by organisms of the genus toxoplasma. (12 Dec 1998) |
| transgenic animal | Genetically engineered animalor offspring of genetically engineeredanimals. The transgenic animal usually contains material from at leaseone unrelated organism, such as from a virus, plant, or other animal. (09 Oct 1997) |
| laboratory animal science | The science and technology dealing with the procurement, breeding, care, health, and selection of animals used in biomedical research and testing. (12 Dec 1998) |
| lameness, animal | A departure from the normal gait in animals. It is also called claudication. (12 Dec 1998) |
| accelerator factor | <chemical> Heat- and storage-labile plasma glycoprotein which accelerates the conversion of prothrombin to thrombin in blood coagulation. Factor v accomplishes this by forming a complex with factor xa, phospholipid, and calcium (prothrombinase complex). Deficiency of factor v leads to owren's disease. Chemical name: Blood-coagulation factor V (12 Dec 1998) |
| acetate replacement factor | <biochemistry> 1,2 dithiolane 3 valeric acid. Regarded as a coenzyme in the oxoglutarate dehydrogenase complex of the citric acid cycle. Involved generally in oxidative decarboxylations of _ keto acids. A growth factor for some organisms. (18 Nov 1997) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|